废除PDK4通过ASK1/JNK通路激活乳腺癌中的自依赖性铁亡
Wenbiao Shi1, Jian Wang1, Jianbin Chen1
1Department of Surgical Oncology, Taizhou Municipal Hospital, No.381 Zhongshan East Road, Jiaojiang District, Taizhou City, 318000, Zhejiang Province, China.
酸盐脱酶激酶单酶4 (PDK4) 缺乏通过激活ASK1/JNK通路,促进乳腺癌的自依赖性铁化. 这一发现为乳腺癌治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌是一个全球性的健康问题.
- 针对由自调节的细胞死亡途径铁亡,是一种有前途的治疗策略.
- 酸盐脱酶激酶异酶4 (PDK4) 在乳腺癌新陈代谢中起作用.
研究的目的:
- 为了研究PDK4在乳腺癌中自依赖性铁亡中的作用.
- 阐明PDK4功能的潜在分子机制.
主要方法:
- 定量实时PCR (RT-qPCR) 和西部抹杀来评估PDK4表达.
- 为光链3 (LC3) 进行免疫光染色,以评估自.
- 铁测定和脂质过氧化染色测量铁.
- 对活性氧物种 (ROS) 和用于途径分析 (ASK1/JNK) 的西方斑点测试.
主要成果:
- 发现PDK4在乳腺癌细胞中表达高.
- PDK4的倒置诱导了自和铁,而自抑制剂 (3-MA) 则部分逆转了这种情况.
- 抑制PDK4激活了ASK1/JNK通路,并且抑制ASK1部分阻止了这些效应.
结论:
- 在乳腺癌中,PDK4 缺乏会刺激自依赖性铁亡.
- ASK1/JNK通路参与调解PDK4对自和铁亡的作用.
- 这些发现突出了PDK4作为乳腺癌潜在的治疗点.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
